Your browser doesn't support javascript.
loading
Promoter methylation status of ASC/TMS1/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC).
Sutic, Maja; Motzek, Antje; Bubanovic, Gordana; Linke, Matthias; Sabol, Ivan; Vugrek, Oliver; Ozretic, Petar; Brcic, Luka; Seiwerth, Sven; Debeljak, Zeljko; Jakovcevic, Antonija; Janevski, Zoran; Stancic-Rokotov, Dinko; Vukic-Dugac, Andrea; Jakopovic, Marko; Samarzija, Miroslav; Zechner, Ulrich; Knezevic, Jelena.
Afiliación
  • Sutic M; Ruder Boskovic Institute, Division for Molecular Medicine, Zagreb, Croatia.
  • Motzek A; Institute for Human Genetics, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Bubanovic G; Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Linke M; Institute for Human Genetics, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Sabol I; Ruder Boskovic Institute, Division for Molecular Medicine, Zagreb, Croatia.
  • Vugrek O; Ruder Boskovic Institute, Division for Molecular Medicine, Zagreb, Croatia.
  • Ozretic P; Ruder Boskovic Institute, Division for Molecular Medicine, Zagreb, Croatia.
  • Brcic L; Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Seiwerth S; Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Debeljak Z; Institute of Clinical Laboratory Diagnostics, University Hospital Osijek, Osijek, Croatia.
  • Jakovcevic A; Faculty of Medicine, Department of Pharmacology, JJ Strossmayer University of Osijek, Osijek, Croatia.
  • Janevski Z; Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Stancic-Rokotov D; Department of Thoracic Surgery Jordanovac, Clinical Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Vukic-Dugac A; Department of Thoracic Surgery Jordanovac, Clinical Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Jakopovic M; Department for Respiratory Diseases, Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Samarzija M; Department for Respiratory Diseases, Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Zechner U; Department for Respiratory Diseases, Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Knezevic J; Institute for Human Genetics, Johannes Gutenberg-University Mainz, Mainz, Germany.
Transl Lung Cancer Res ; 8(6): 1000-1015, 2019 Dec.
Article en En | MEDLINE | ID: mdl-32010578
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Transl Lung Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Croacia Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Transl Lung Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Croacia Pais de publicación: China